Preoperative Predictors of Early Recurrence After Liver Resection for Multifocal Hepatocellular Carcinoma

被引:4
|
作者
Guo, Yuxin [1 ,2 ]
Linn, Yun Le [1 ,2 ,3 ]
Koh, Ye Xin [1 ,2 ,3 ,4 ]
Tan, Ek Khoon [1 ,2 ,3 ,4 ]
Teo, Jin Yao [1 ,2 ,3 ]
Cheow, Peng Chung [1 ,2 ,3 ,4 ]
Jeyaraj, Prema Raj [1 ,2 ,3 ,4 ]
Chow, Pierce K. H. [1 ,2 ,3 ]
Ooi, London L. P. J. [1 ,2 ,3 ]
Chung, Alexander Y. F. [1 ,2 ,3 ,4 ]
Chan, Chung Yip [1 ,2 ,3 ,4 ]
Goh, Brian K. P. [1 ,2 ,3 ,4 ]
机构
[1] Singapore Gen Hosp, Acad, Dept Hepatopancreatobiliary & Transplant Surg, 20 Coll Rd, Singapore 169856, Singapore
[2] Natl Canc Ctr Singapore, Acad, 20 Coll Rd, Singapore 169856, Singapore
[3] Duke Natl Univ Singapore Med Sch, Singapore, Singapore
[4] SingHealth Duke Natl Univ Singapore Transplant Ctr, Liver Transplant Serv, Singapore, Singapore
关键词
Hepatocellular carcinoma; Liver resection; Futile; Early recurrence; Multifocal; TO-LYMPHOCYTE RATIO; PROGNOSTIC NUTRITIONAL INDEX; TRANSCATHETER ARTERIAL CHEMOEMBOLIZATION; HEPATITIS-B; MILAN CRITERIA; RISK-FACTORS; SURVIVAL; OUTCOMES; TRANSPLANTATION; INTERMEDIATE;
D O I
10.1007/s11605-023-05592-1
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background Liver transplantation remains the optimal treatment for multifocal hepatocellular carcinoma (HCC). However, due to resource constrains, other therapeutic modalities such as liver resection (LR), are frequently utilized. LR, however, has to be balanced against potential morbidity and mortality along with the risks of early recurrence leading to futile surgery. In this study, we evaluated preoperative factors, including inflammatory indices, in predicting early (< 1 year) recurrence in patients who underwent LR for multifocal HCC. Methods This was a post hoc analysis of 250 consecutive patients with multifocal HCC who underwent LR. Results After exclusion of 10 patients with 30-day/in-hospital mortality, 240 were included of which 134 (55.8%) developed early recurrence. Hepatitis B/C aetiology, 3/ > more hepatic nodules and elevated alpha-fetoprotein (AFP) >= 200 ng/ml were significant independent preoperative predictors of early recurrence. The early recurrence rate was 72.1% when 2 out of 3 significant predictive factors were present. The conglomerate of all 3 factors predicted early recurrence of 100% with a statistically significant association between number of predictive factors and early recurrence (p < 0.001). Conclusion Better patient selection via the use of preoperative predictive factors of early recurrence such as hepatitis B/C aetiology, >= 3 nodules and elevated AFP >= 200 ng/ml may assist in identifying patients in whom LR is deemed futile and improve resource allocation.
引用
收藏
页码:1106 / 1112
页数:7
相关论文
共 50 条
  • [41] Salvage liver transplantation for hepatocellular carcinoma recurrence after primary liver resection
    Qu, Wei
    Zhu, Zhi-Jun
    Sun, Li-Ying
    Wei, Lin
    Liu, Ying
    Zeng, Zhi-Gui
    CLINICS AND RESEARCH IN HEPATOLOGY AND GASTROENTEROLOGY, 2015, 39 (01) : 93 - 97
  • [42] Outcomes after hepatic resection and subsequent multimodal treatment of recurrence for multifocal hepatocellular carcinoma
    Kim, P. T. W.
    Jang, J. -H.
    Atenafu, E. G.
    Fischer, S.
    Greig, P. D.
    McGilvray, I. D.
    Wei, A. C.
    Gallinger, S.
    Cleary, S. P.
    BRITISH JOURNAL OF SURGERY, 2013, 100 (11) : 1516 - 1522
  • [43] Evolutionary Distance Predicts Recurrence After Liver Transplantation in Multifocal Hepatocellular Carcinoma
    Heits, Nils
    Brosch, Mario
    Herrmann, Alexander
    Behrens, Robin
    Roecken, Christoph
    Schrem, Harald
    Kaltenborn, Alexander
    Klempnauer, Juergen
    Kreipe, Hans-Heinrich
    Reichert, Benedikt
    Lenschow, Christina
    Wilms, Christian
    Vogel, Thomas
    Wolters, Heiner
    Wardelmann, Eva
    Seehofer, Daniel
    Buch, Stephan
    Zeissig, Sebastian
    Pannach, Sven
    Raschzok, Nathanael
    Dietel, Manfred
    von Schoenfels, Witigo
    Hinz, Sebastian
    Teufel, Andreas
    Evert, Matthias
    Franke, Andre
    Becker, Thomas
    Braun, Felix
    Hampe, Jochen
    Schafmayer, Clemens
    TRANSPLANTATION, 2018, 102 (10) : E424 - E430
  • [44] Recurrence after liver resection for hepatocellular carcinoma in cirrhotic and noncirrhotic patients
    Lanthaler, Monika
    Biebl, Matthias
    Weissenbacher, Annemarie
    Margreiter, Raimund
    Nehoda, Hermann
    CHIRURGISCHE GASTROENTEROLOGIE, 2008, 24 (01): : 51 - 54
  • [45] RECURRENCE OF HEPATOCELLULAR-CARCINOMA IN THE LIVER REMNANT AFTER HEPATIC RESECTION
    OUCHI, K
    MATSUBARA, S
    FUKUHARA, K
    TOMINAGA, T
    MATSUNO, S
    AMERICAN JOURNAL OF SURGERY, 1993, 166 (03): : 270 - 273
  • [46] REMNANT LIVER ISCHEMIA IS ASSOCIATED WITH EARLY RECURRENCE AND POORER SURVIVAL AFTER LIVER RESECTION IN PATIENTS WITH HEPATOCELLULAR CARCINOMA
    Cho, J. Y.
    Choi, Y.
    Jang, J. S.
    Kim, H.
    JOURNAL OF HEPATOLOGY, 2016, 64 : S693 - S693
  • [47] Pathologic response to preoperative transarterial chemoembolization for resectable hepatocellular carcinoma may not predict recurrence after liver resection
    Kwang Yeol Paik
    Eung Kook Kim
    Hepatobiliary & Pancreatic Diseases International, 2016, 15 (02) : 158 - 164
  • [48] Pathologic response to preoperative transarterial chemoembolization for resectable hepatocellular carcinoma may not predict recurrence after liver resection
    Paik, Kwang Yeol
    Kim, Eung Kook
    HEPATOBILIARY & PANCREATIC DISEASES INTERNATIONAL, 2016, 15 (02) : 158 - 164
  • [49] Survival Benefit of Transplantation for Recurrence of Hepatocellular Carcinoma After Liver Resection
    Tuci, F.
    Vitale, A.
    D'Amico, F.
    Gringeri, E.
    Neri, D.
    Zanus, G.
    Bassi, D.
    Polacco, M.
    Boetto, R.
    Lodo, E.
    Germani, G.
    Burra, P.
    Angeli, P.
    Cillo, U.
    TRANSPLANTATION PROCEEDINGS, 2014, 46 (07) : 2287 - 2289
  • [50] Association of Remnant Liver Ischemia With Early Recurrence and Poor Survival After Liver Resection in Patients With Hepatocellular Carcinoma
    Cho, Jai Young
    Han, Ho-Seong
    Choi, YoungRok
    Yoon, Yoo-Seok
    Kim, Sungho
    Choi, Jang Kyu
    Jang, Jae Seong
    Kwon, Seong Uk
    Kim, Haeryoung
    JAMA SURGERY, 2017, 152 (04) : 386 - 392